AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 293: F1065-F1071, 2007. First published August 1, 2007; doi:10.1152/ajprenal.00147.2007
0363-6127/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/4/F1065    most recent
00147.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patni, H.
Right arrow Articles by Singhal, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patni, H.
Right arrow Articles by Singhal, P. C.

Aldosterone promotes proximal tubular cell apoptosis: role of oxidative stress

Hitesh Patni,1 Jayant T. Mathew,1 Liming Luan,1 Nicholas Franki,1 Praveen N. Chander,2 and Pravin C. Singhal1

1Department of Medicine, North Shore University Hospital and Long Island Jewish Medical Center, New Hyde Park; and 2Department of Pathology, New York Medical College, Valhalla, New York

Submitted 28 March 2007 ; accepted in final form 26 July 2007

Aldosterone has attracted significant consideration for its role in the progression of renal injury. Since apoptotic cell loss contributes to the deterioration of renal function, we examined the effect of aldosterone on tubular cell apoptosis. To determine dose and time course effect, human renal proximal tubular (HK2) cells were treated with aldosterone at different doses and for variable time periods followed by evaluation for apoptosis. To determine the role of mineralocorticoid receptors (MR) and oxidative stress, HK2 cells were treated with either vehicle or aldosterone in the presence or absence of spironolactone/antioxidants/free radical scavengers (FRS) followed by evaluation for apoptosis. The presence of MR was evaluated using RT-PCR. Reactive oxygen species (ROS) generation was evaluated using redox-sensitive dyes. Effect of aldosterone was evaluated on dephosphorylation of phospho-Bad and accumulation of cytosolic cytochrome c. Human tubular cells express MR. Aldosterone promotes tubular cell apoptosis in a dose- and time-dependent manner. This effect of aldosterone is mediated through MR and associated with generation of ROS. Antioxidants and FRS partially attenuated the proapoaptotic effect of aldosterone. Aldosterone enhanced dephosphorylation of phospho-Bad and accumulation of cytosolic cytochrome c. We conclude that aldosterone-induced tubular cell apoptosis is mediated through the activation of the mitochondrial pathway and generation of ROS.

reactive oxygen species; mineralocorticoid receptor



Address for reprint requests and other correspondence: P. C. Singhal, Division of Kidney Diseases and Hypertension, Long Island Jewish Medical Center, 410 Lakeville Rd., Ste. 105, New Hyde Park, NY 11042 (e-mail: singhal{at}lij.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. S. De Silva, R. M. Wilson, C. Hutchinson, P. C. Ip, A. G. Garcia, S. Lancel, M. Ito, D. R. Pimentel, and F. Sam
Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms
Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1983 - H1993.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
M. Cortinovis, N. Perico, D. Cattaneo, and G. Remuzzi
Aldosterone and progression of kidney disease
Therapeutic Advances in Cardiovascular Disease, April 1, 2009; 3(2): 133 - 143.
[Abstract] [PDF]


Home page
HypertensionHome page
Y. Wei, A. T. Whaley-Connell, J. Habibi, J. Rehmer, N. Rehmer, K. Patel, M. Hayden, V. DeMarco, C. M. Ferrario, J. A. Ibdah, et al.
Mineralocorticoid Receptor Antagonism Attenuates Vascular Apoptosis and Injury via Rescuing Protein Kinase B Activation
Hypertension, February 1, 2009; 53(2): 158 - 165.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. Remuzzi, D. Cattaneo, and N. Perico
The Aggravating Mechanisms of Aldosterone on Kidney Fibrosis
J. Am. Soc. Nephrol., August 1, 2008; 19(8): 1459 - 1462.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. J. Brown
Aldosterone and Vascular Inflammation
Hypertension, February 1, 2008; 51(2): 161 - 167.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.